
Michael Browning
Articles
-
Sep 30, 2024 |
techcommunity.microsoft.com | Michael Browning
We are thrilled to introduce Microsoft Defender Threat Intelligence (MDTI) with FedRAMP High (DOD IL2) attestation are now available for government sectors. Customers across U.S. state, local, and tribal governments utilizing GCC services can now purchase MDTI and the MDTI API SKUs to unmask adversaries and understand their organization’s security posture against threats.
-
Sep 30, 2024 |
techcommunity.microsoft.com | Michael Browning
The Copilot for Security team is continuously enhancing threat intelligence (TI) capabilities in Copilot for Security to provide a more comprehensive and integrated TI experience for customers. We're excited to share that the Copilot for Security threat Intelligence plugin has broadened beyond just MDTI to now encapsulate data from other TI sources, including Microsoft Threat Analytics (TA) and SONAR, with even more sources becoming available soon.
-
Aug 20, 2024 |
techcommunity.microsoft.com | Michael Browning
The MDTI team is excited to introduce the MDTI Article Digest, a new way for customers to stay up to speed with the latest analysis of threat activity observed across more than 78 trillion daily threat signals from Microsoft's interdisciplinary teams of experts worldwide.
-
Aug 16, 2024 |
techcommunity.microsoft.com | Michael Browning
The MDTI and Unified Security Operations Platform teams are excited to introduce an MDTI premium data connector available in the Unified Security Operations Platform and standalone Microsoft Sentinel experiences. This connector enables customers with an MDTI premium license and API license to apply the powerful raw and finished threat intelligence in MDTI, including high-fidelity indicators of compromise (IoCs), across their security operations to detect and respond to the latest threats.
-
Aug 8, 2024 |
nature.com | Michael Colwell |Hosana Tagomori |Michael Browning |Philip J Cowen
AbstractThe role of serotonin in human behaviour is informed by approaches which allow in vivo modification of synaptic serotonin. However, characterising the effects of increased serotonin signalling in human models of behaviour is challenging given the limitations of available experimental probes, notably selective serotonin reuptake inhibitors.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →